APA (7th ed.) Citation

Yuan, P. D., Hu, Y. W., Chen, X. Q., Chen, G. Y., Pan, Y., Lao, H. Y., & Liang, D. (2025). Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study. Ocular Immunology & Inflammation, 33(3), 332. https://doi.org/10.1080/09273948.2024.2343084

Chicago Style (17th ed.) Citation

Yuan, P. D., Y. W. Hu, X. Q. Chen, G. Y. Chen, Y. Pan, H. Y. Lao, and D. Liang. "Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study." Ocular Immunology & Inflammation 33, no. 3 (2025): 332. https://doi.org/10.1080/09273948.2024.2343084.

MLA (9th ed.) Citation

Yuan, P. D., et al. "Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study." Ocular Immunology & Inflammation, vol. 33, no. 3, 2025, p. 332, https://doi.org/10.1080/09273948.2024.2343084.